Delpharm has acquired the Boucherville manufacturing plant owned by Sandoz Canada, in Québec. This plant is the largest sterile injectable production facility in Canada and provides medicines to the Canadian and U.S. healthcare systems, mostly hospitals.  “We are proud to acquire this manufacturing facility in Boucherville, which represents our 2nd production site in Canada. This acquisition will allow us to propose sterile manufacturing to the North American market,” said Sébastien Aguett...